About Native Antigen
Native Antigen is a company based in Upper Heyford (United Kingdom) founded in 2010 was acquired by LGC in July 2020.. Native Antigen has raised $1.1 million across 5 funding rounds from investors including Mercia and LGC. The company has 28 employees as of July 31, 2020. Native Antigen offers products and services including Antigens and Antibodies, Virus-Like Particles, Immunoassays, Toxins, and Protein Conjugation Kits. Native Antigen operates in a competitive market with competitors including Nautilus Biotechnology, Somalogic, ProteinSimple, Amunix and Dynamic Biosensors, among others.
- Headquarter Upper Heyford, United Kingdom
- Employees 28 as on 31 Jul, 2020
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name The Native Antigen Company Limited
- Date of Incorporation 23 Sep, 2010
- Jurisdiction TEDDINGTON, ENGLAND
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Native Antigen
Native Antigen offers a comprehensive portfolio of products and services, including Antigens and Antibodies, Virus-Like Particles, Immunoassays, Toxins, and Protein Conjugation Kits. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Products for detecting viral and bacterial pathogens in research.
Simulated particles for vaccine and diagnostic development.
Kits for antibody detection in disease testing.
Substances for studying bacterial infections.
Kits for labeling proteins in assays.
Funding Insights of Native Antigen
Native Antigen has successfully raised a total of $1.1M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $179.72 thousand completed in June 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series A — $179,723
-
First Round
First Round
(05 Dec 2010)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2015 | Amount | Series A - Native Antigen | Valuation |
investors |
|
| Nov, 2014 | Amount | Series A - Native Antigen | Valuation |
investors |
|
| Apr, 2013 | Amount | Series A - Native Antigen | Valuation | Mercia |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Native Antigen
Native Antigen has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Mercia and LGC. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment management services are provided by Mercia to various clients.
|
Founded Year | Domain | Location | |
|
Molecular biology reagents and services are supplied to biotech industries.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Native Antigen
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Native Antigen
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Native Antigen Comparisons
Competitors of Native Antigen
Native Antigen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nautilus Biotechnology, Somalogic, ProteinSimple, Amunix and Dynamic Biosensors, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
A proteomics platform is developed for analyzing the human proteome.
|
|
| domain | founded_year | HQ Location |
Protein-based assays are developed for life science research.
|
|
| domain | founded_year | HQ Location |
Provider tools to help researchers with protein analysis
|
|
| domain | founded_year | HQ Location |
Peptide-based therapeutics are developed for cancers and immune disorders.
|
|
| domain | founded_year | HQ Location |
Label-free solutions for molecular interactions and biophysical analysis are provided.
|
|
| domain | founded_year | HQ Location |
Proteomics services are delivered via discovery and targeted platforms.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Native Antigen
Frequently Asked Questions about Native Antigen
When was Native Antigen founded?
Native Antigen was founded in 2010.
Where is Native Antigen located?
Native Antigen is headquartered in Upper Heyford, United Kingdom. It is registered at Upper Heyford, England, United Kingdom.
Is Native Antigen a funded company?
Native Antigen is a funded company, having raised a total of $1.1M across 5 funding rounds to date.
How many employees does Native Antigen have?
As of Jul 31, 2020, the latest employee count at Native Antigen is 28.
What does Native Antigen do?
Founded in 2010, Native Antigen is based in Upper Heyford, United Kingdom, and operates in the biotechnology sector. Native and recombinant viral and bacterial antigens are developed and manufactured for use by pharmaceutical and in vitro diagnostic manufacturers in vaccine research and serology applications, where proper folding and glycosylation are required. Bespoke product development and custom manufacturing are also undertaken using a proprietary mammalian cell protein expression system.
Who are the top competitors of Native Antigen?
Native Antigen's top competitors include Somalogic, Nautilus Biotechnology and Elektrofi.
What products or services does Native Antigen offer?
Native Antigen offers Antigens and Antibodies, Virus-Like Particles, Immunoassays, Toxins, and Protein Conjugation Kits.